.png)
Agenzia Italiana del Farmaco
Monitoring of oral antivirals for COVID-19: third report published - Monitoring of oral antivirals for COVID-19: third report published
Monitoring of oral antivirals for COVID-19: third report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of oral antivirals currently available for treating COVID-19. The monitoring was carried out through the AIFA registry, which was developed in implementation of the Decree of the Ministry of Health 29 November 2021 and published in the Official Gazette no. 295 of 13 December 2021.
Published on: 04 February 2022
Oggi si celebra il #WorldAutismAwarenessDay.
🔵 L'Agenzia Italiana del Farmaco sostiene la Giornata...
Vai al post →
Jelena Ivanovic, dirigente medico dell’Ufficio Procedure Europee di #HTA di #AIFA, è stata eletta Co...
Vai al post →
Biosimilari: webinar AIFA su terzo Position Paper
La Commissione Scientifica ed Economica (CSE) di ...
Vai al post →
🎙️ Il Presidente #AIFA intervistato da @presadirettarai sulle false terapie a base di cellule stami...
Vai al post →
💛 28 marzo 2026 – Giornata Mondiale dell’Endometriosi 💛
#AIFA si illumina di giallo per accendere...
Vai al post →
🤝🌍 A Roma i lavori dell’EDQM Borderline Products Network Meeting
💬 Il meeting, ospitato da #AIFA...
Vai al post →
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR